ADVISORY/FDA Approves Novartis` Unique Leukemia Medication Gleevec
(Business Wire)...Novartis today announced that the United States Food and Drug Administration (FDA) approved its drug Gleevec(tm) (imatinib mesylate) as an oral therapy for the treatment of patients with chronic myeloid leukemia (CML) in the blast crisis,...- May 10 3:31 PM ET
Al Musella's Comments: (This is his personal views and are not necessarily the views of the Musella Foundation!)
Posted on: 05/10/2001
"Yahoo - ADVISORY/FDA Approves Novartis' Unique Leukemia Medication Gleevec"
[ Latest Headlines
News Alerts ]
Thursday May 10, 3:31 pm Eastern Time
ADVISORY/FDA Approves Novartis' Unique Leukemia Medication Gleevec
Novartis today announced that the United States Food and Drug
Administration (FDA) approved its drug Gleevec(tm) (imatinib mesylate)
as an oral therapy for the treatment of patients with chronic myeloid
leukemia (CML) in the blast crisis, accelerated phase or in chronic
phase after failure of interferon-alpha therapy. The effectiveness of
Gleevec is based on overall hematologic and cytogenetic response
rates. Video and photos coming later.
You can reach the story directly by going to
This multimedia news story is for free and unrestricted use on
your news information site (and for print or broadcast too). Visit
http://www.newstream.com to download video, audio, text, graphics, and
If you have any questions about the story, or about Newstream.com,
please write to us at firstname.lastname@example.org.
Newstream.com, New York
Les Blatt, 888/560-5578
Email this story - Most-emailed articles - Most-viewed articles
Copyright © 2001 Yahoo! Inc. All rights reserved.
Terms of Service
Copyright © 2001 Business
All rights reserved.
All the news releases provided by Business Wire are
Any forms of copying other than an individual user's
without express written permission is prohibited.
Further distribution of these materials is strictly
forbidden, including but
not limited to, posting, emailing, faxing, archiving
in a public database,
redistributing via a computer network or in a printed
Questions or Comments?
Click HERE to return to brain tumor news headlines